Insulin Therapy for the Management of Hyperglycemia in Hospitalized Patients
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
It has long been established that hyperglycemia with or without a prior diagnosis of diabetes increases both mortality and disease-specific morbidity in hospitalized patients1–4 and that goal-directed insulin therapy can improve outcomes.5–9 During the past decade, since the widespread institutional adoption of intensified insulin protocols after the publication of a landmark trial,5,10 the pendulum in the inpatient diabetes literature has swung away from achieving intensive glucose control and toward more moderate and individualized glycemic targets.11,12 This change in clinical practice is the result of several factors, including challenges faced by hospitals to coordinate glycemic control across all levels of care,13,14 publication of negative prospective trials,15,16 revised recommendations from professional organizations,17,18 and increasing evidence on the deleterious effect of hypoglycemia.19–22 This article reviews the pathophysiology of hyperglycemia during illness, the mechanisms for increased complications and mortality due to hyperglycemia and hypoglycemia, beneficial mechanistic effects of insulin therapy and provides updated recommendations for the inpatient management of diabetes in the critical care setting and in the general medicine and surgical settings.23,24
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“15 Recent randomized controlled trials, however, have shown that intensive glycemic control (target glucose 110 mg/dL) has been difficult to achieve without increasing the risk for severe hypoglycemia, 16,80–82 causing some to be discontinued early (Table 2).”
BackgroundMcClave, S. A., Taylor, B. E., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115621863 · Cited by 3,982
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 2×
“5 In a different study, these investigators following the same protocol in medical ICU patients also reported less ICU and hospital mortality after 3 days of treatment with CII.”
MethodStandards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 1×
“15 Recent randomized controlled trials, however, have shown that intensive glycemic control (target glucose 110 mg/dL) has been difficult to achieve without increasing the risk for severe hypoglycemia, 16,80–82 causing some to be discontinued early (Table 2).”
BackgroundHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationCapes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
Self-citationEsposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961 · cited 1×
“45,46 Acute stress increases proinflammatory cytokines, such as tumor necrosis factor (TNF)- α , interleukin (IL)-6, and IL-1, 34,47–49 which increase insulin resistance by interfering with insulin signaling.”
BackgroundESPEN guidelines on parenteral nutrition: intensive care
Singer, P., Berger, M. M., Van den Berghe, G., Biolo, G., Calder, P., Forbes, A., Griffiths, R., Kreyman, G., Leverve, X., & Pichard, C. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.04.024 · Cited by 1,907
McClave, S. A., Martindale, R. G., Vanek, V. W., McCarthy, M., Roberts, P., Taylor, B., Ochoa, J. B., Napolitano, L., Cresci, G., the A.S.P.E.N. Board of Directors, et al. (2009) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607109335234 · Cited by 1,873
Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824 · cited 2×
“During the progression of stroke, the area of ischemic penumbra (the region of the brain tissue surrounding the core of infarcted tissue where neurons still viable) is more sensitive to ischemic injury.(70,72)”
BackgroundMalmberg, K., Rydén, L., Efendic, S., Herlitz, J., Nicol, P., Waldenstrom, A., Wedel, H., & Welin, L. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00126-k · Cited by 1,560 · cited 1×
“litus receiving CII in critical care setting require transitioning to a subcutaneous insulin regimen.(9,18,142,143) Several models have been proposed for transition from insulin infusion to subcutaneous insulin therapy.”
BackgroundTaylor, B. E., McClave, S. A., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001525 · Cited by 1,476
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471 · cited 1×
“These studies raised the possibility that hypoglycemia is a marker of disease burden rather than a direct cause of death.(22,162,167)”
BackgroundMoghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E. (2009) · Diabetes Care · doi:10.2337/dc09-9029 · Cited by 1,444
Self-citationCryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277 · cited 1×
“2 mmol/ L (40 mg/dL).(158) The incidence of severe hypoglycemia among the different trials”
BackgroundManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
McCowen, K. C., Malhotra, A., & Bistrian, B. R. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70154-8 · Cited by 1,170
Furnary, A. P., Gao, G., Grunkemeier, G. L., Wu, Y., Zerr, K. J., Bookin, S. O., Floten, H. S., & Starr, A. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.181 · Cited by 1,130
Griesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090206 · Cited by 1,096
Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911
Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
Steinberg, H. O., Tarshoby, M., Monestel, R., Hook, G., Cronin, J., Johnson, A., Bayazeed, B., & Baron, A. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119636 · Cited by 761
Umpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M. (2011) · Diabetes Care · doi:10.2337/dc10-1407 · Cited by 720
Self-citationSevere hypoglycemia in critically ill patients: risk factors and outcomes
Krinsley, J. S., & Grover, A. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000282073.98414.4b · Cited by 671
Umpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Self-citationHyperglycemia-related mortality in critically ill patients varies with admission diagnosis
Falciglia, M., Freyberg, R. W., Almenoff, P. L., D’Alessio, D. A., & Render, M. L. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b083f7 · Cited by 576
Lang, C. H., Dobrescu, C., & Bagby, G. J. (1992) · Endocrinology · doi:10.1210/endo.130.1.1727716 · Cited by 535
Stentz, F. B., Umpierrez, G. E., Cuervo, R., & Kitabchi, A. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2079 · Cited by 497 · cited 1×
“inflammatory markers associated with severe hyperglycemia return to normal shortly after the treatment with insulin and resolution of hyperglycemia.(48) Insulin acts to”
BackgroundSelf-citationHypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward
Turchin, A., Matheny, M. E., Shubina, M., Scanlon, J. V., Greenwood, B., & Pendergrass, M. L. (2009) · Diabetes Care · doi:10.2337/dc08-2127 · Cited by 453
Hypoglycemia and outcome in critically ill patients
Egi, M., Bellomo, R., Stachowski, E., French, C. J., Hart, G. K., Taori, G., Hegarty, C., & Bailey, M. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0394 · Cited by 432
Management of Hyperglycemia in the Hospital Setting
Inzucchi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060094 · Cited by 391
Effects of glucocorticoids on carbohydrate metabolism
Mcmahon, M., Gerich, J., & Rizza, R. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040105 · Cited by 390 · cited 1×
“stimulate protein catabolism, and increase circulating amino acids concentration, providing precursors for gluconeogenesis.(45,46) Acute stress increases proinflammatory cytokines, such as tumor necrosis factor (TNF)-a, interleukin (IL)-6, and IL-1, which increase insulin resistance by interfering with insulin signali…”
BackgroundRamos, M., Khalpey, Z., Lipsitz, S., Steinberg, J., Panizales, M. T., Zinner, M., & Rogers, S. O. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31818990d1 · Cited by 380 · cited 1×
“2 mmol/L (40 mg/dL) rise in the presence of hyperglycemia.(91) A recent study in 3184 general surgery patients in non-ICU setting reported a strong association between presurgery and postsurgery hyperglycemia and postoperative cases of pneumonia, systemic”
BackgroundHypoglycemia, functional brain failure, and brain death.
Cryer, P. E. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31669 · Cited by 363
De La Rosa, G. D. C., Donado, J. H., Restrepo, A. H., Quintero, A. M., González, L. G., Saldarriaga, N. E., Bedoya, M., Toro, J. M., Velásquez, J. B., Valencia, J. C., et al. (2008) · Critical Care · doi:10.1186/cc7017 · Cited by 319
Multiple hospitalizations for patients with diabetes
Jiang, H. J., Stryer, D., Friedman, B., & Andrews, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1421 · Cited by 261
Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients
Donihi, A. C., Raval, D., Saul, M., Korytkowski, M. T., & DeVita, M. A. (2006) · Endocrine Practice · doi:10.4158/ep.12.4.358 · Cited by 246 · cited 1×
“Finally, the specific morbidities due to secondary causes of hyperglycemia, such as steroid-exacerbated hyperglycemia, remain largely unknown.(101) Hospital care of patients with diabetes and hyperglycemia is complex,”
BackgroundKavanagh, B. P., & McCowen, K. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmcp1001115 · Cited by 205 · cited 1×
“the past decade, since the widespread institutional adoption of intensified insulin protocols after the publication of a landmark trial,(5,10) the pendulum in the inpatient diabetes literature has swung away from achieving intensive glucose control and toward more moderate and individualized glycemic targets.(11,12) T…”
BackgroundDrug-Induced Hypoglycemic Coma in 102 Diabetic Patients
Ben-Ami, H., Nagachandran, P., Mendelson, A., & Edoute, Y. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.3.281 · Cited by 201
Benefits and Risks of Tight Glucose Control in Critically Ill Adults: A Meta-analysis
Wiener, R. S., Wiener, D. C., & Larson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.933 · Cited by 200
Blood glucose variability is associated with mortality in the surgical intensive care unit
Dossett, L. A., Cao, H., Mowery, N. T., Dortch, M. J., Morris, J. M., & May, A. K. (2008) · The American Surgeon™ · doi:10.1177/000313480807400802 · Cited by 190
Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities
Boucai, L., Southern, W. N., & Zonszein, J. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.07.011 · Cited by 175 · cited 2×
“These studies raised the possibility that hypoglycemia is a marker of disease burden rather than a direct cause of death.(22,162,167)”
BackgroundTight glucose control in the intensive care unit: Are glucose meters up to the task?
Scott, M. G., Bruns, D. E., Boyd, J. C., & Sacks, D. B. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.117291 · Cited by 162
Pandolfi, A., Giaccari, A., Cilli, C., Alberta, M. M., Morviducci, L., De Filippis, E. A., Buongiorno, A., Pellegrini, G., Capani, G., & Consoli, A. (2001) · Acta Diabetologica · doi:10.1007/s005920170016 · Cited by 144
Postoperative diet advancement: Surgical dogma vs evidence-based medicine
Warren, J., Bhalla, V., & Cresci, G. (2011) · Nutrition in Clinical Practice · doi:10.1177/0884533611400231 · Cited by 95 · cited 2×
“should be initiated as quickly as possible with progression from clear liquids to full liquids to solid foods as rapidly as tolerated.(112,114) Increasing evidence, however, indi-”
BackgroundNewton, C. A., Smiley, D., Bode, B. W., Kitabchi, A. E., Davidson, P. C., Jacobs, S., Steed, R. D., Stentz, F., Peng, L., Mulligan, P., et al. (2010) · Journal of Hospital Medicine · doi:10.1002/jhm.816 · Cited by 84
Self-citationICU care for patients with diabetes
Umpierrez, G. E., & Kitabchi, A. E. (2004) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000129636.04145.84 · Cited by 35
Self-citationTight glucose control and hypoglycemia
Preiser, J.-C., & Brunkhorst, F. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31816a16d0 · Cited by 25
Cited by
Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline
LeRoith, D., Biessels, G. J., Braithwaite, S. S., Casanueva, F. F., Draznin, B., Halter, J. B., Hirsch, I. B., McDonnell, M. E., Molitch, M. E., Murad, M. H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00198 · Cited by 568
Self-citationPerioperative management of hyperglycemia and diabetes in cardiac surgery patients
Galindo, R. J., Fayfman, M., & Umpierrez, G. E. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.005 · Cited by 95
Self-citationVellanki, P., Bean, R., Oyedokun, F. A., Pasquel, F. J., Smiley, D., Farrokhi, F., Newton, C., Peng, L., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc14-1796 · Cited by 36
“The basal-bolus approach requires subcutaneous administration of basal insulin given once or twice daily in combination with prandial and corrective doses of rapid-acting insulin before each meal (4,9).”
BackgroundSelf-citationTransitioning safely from intravenous to subcutaneous insulin
Kreider, K. E., & Lien, L. F. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0595-4 · Cited by 36
Management of type 1 diabetes in the hospital setting
Mendez, C. E., & Umpierrez, G. E. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0919-7 · Cited by 34
Self-citation
Metadata
- Authors
- McDonnell, M. E., & Umpierrez, G. E.
- Venue
- Endocrinology and Metabolism Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 41
- Issue
- 1
- Pages
- 175-201
- ISSN
- 0889-8529 (ISSN-L)
- OpenAlex
- W2052366813
- Cited by
- 117
- References
- 50
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.